BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 19808352)

  • 1. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
    Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
    Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. γ-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure.
    Ess M; Mussner-Seeber C; Mariacher S; Lorsbach-Koehler A; Pachinger O; Frick M; Ulmer H; Poelzl G
    J Card Fail; 2011 Jul; 17(7):577-84. PubMed ID: 21703530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
    Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
    Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
    Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
    Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
    Ceconi C; Ferrari R; Bachetti T; Opasich C; Volterrani M; Colombo B; Parrinello G; Corti A
    Eur Heart J; 2002 Jun; 23(12):967-74. PubMed ID: 12069452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
    Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
    Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin, a new prognostic biomarker in patients with chronic heart failure.
    Rosenberg M; Zugck C; Nelles M; Juenger C; Frank D; Remppis A; Giannitsis E; Katus HA; Frey N
    Circ Heart Fail; 2008 May; 1(1):43-9. PubMed ID: 19808269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease.
    Emdin M; Passino C; Michelassi C; Donato L; Pompella A; Paolicchi A
    Int J Cardiol; 2009 Jul; 136(1):80-5. PubMed ID: 18656271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.
    Stanton EB; Hansen MS; Sole MJ; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL;
    Can J Cardiol; 2005 Jan; 21(1):39-43. PubMed ID: 15685301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
    Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
    Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum phosphate and long-term outcome among patients with stable heart failure.
    Ess M; Heitmair-Wietzorrek K; Frick M; Umlauf N; Ulmer H; Poelzl G
    J Card Fail; 2013 Jan; 19(1):25-30. PubMed ID: 23273591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
    Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
    Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics.
    Grigioni F; Barbieri A; Russo A; Reggianini L; Bonatti S; Potena L; Fabbri F; Coccolo F; Magnani G; Bursi F; Magelli C; Modena MG; Branzi A
    J Heart Lung Transplant; 2006 Jun; 25(6):648-52. PubMed ID: 16730570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
    J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.